CREEK & RIVER (4763) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
20 Jul, 2026Executive summary
Q3 FY02/25 sales reached ¥38,102 million, up 1% year-over-year, but operating profit declined 14% to ¥2,986 million due to project reductions and longer contract times in key segments.
Ordinary profit fell 13.2% to ¥3,059 million, and profit attributable to owners of parent decreased 10.8% to ¥2,031 million.
Earnings per share for the period were ¥94.87, down from ¥103.35 in the prior year.
Profitability improved sequentially since Q2, but full-year forecasts were revised downward due to limited contribution from new projects this fiscal year.
Financial highlights
Sales: ¥38,102 million (101% YoY); Gross profit: ¥14,249 million (99% YoY); Operating profit: ¥2,986 million (86% YoY); Ordinary profit: ¥3,059 million (87% YoY); Net profit: ¥2,031 million (89% YoY).
Gross margin: 37.4% (down from 38.0% YoY); Operating margin: 7.8% (down from 9.2% YoY).
SG&A expenses increased 3% YoY to ¥11,263 million.
Comprehensive income attributable to owners of parent was ¥1,991 million, down from ¥2,315 million YoY.
Total assets increased to ¥27,008 million as of November 30, 2024, from ¥25,418 million as of February 29, 2024.
Outlook and guidance
Full-year sales forecast revised to ¥50,500 million (down ¥4,500 million from previous), operating profit to ¥3,850 million (down ¥950 million), and net profit to ¥2,500 million (down ¥600 million).
Ordinary profit is expected to decrease 5.7% to ¥3,900 million, and full-year earnings per share are projected at ¥116.73.
Dividend forecast revised from ¥43 to ¥41 per share, maintaining a 30% payout ratio.
Latest events from CREEK & RIVER
- Sales up 1% but operating profit down 20.2% YoY; strong full-year recovery forecast.4763
Q1 202420 Jul 2026 - Sales up 2.3% but operating profit down 15.6%; AI/DX and overseas growth prioritized.4763
Q2 202420 Jul 2026 - Record sales and lower profits in FY2025; strong growth and higher dividends forecast for FY2026.4763
Q4 202520 Jul 2026 - Record sales and profit growth, with acquisitions fueling further expansion.4763
Q1 202620 Jul 2026 - Net sales rose 8.7% and profit attributable to owners of parent surged 50.7%.4763
Q2 202620 Jul 2026 - Record sales and profit growth fueled by new segments, M&A, and strong business performance.4763
Q3 202620 Jul 2026 - Record sales and double-digit profit growth, with sales growth forecast to continue.4763
Q4 202620 Jul 2026 - Record Q1 sales and profits, driven by creative, medical, and incubation growth.4763
Q1 202720 Jul 2026